Equillium, Inc. cash flow to debt ratio of -3.16K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Equillium, Inc.'s free cash flow has decreased 19.27% from $-19.11M last year to $-22.79M, signaling decreasing performance

Equillium, Inc.'s debt to equity ratio is 0.01, which means that the company's assets are healthy financed, signaling financial stability.

Equillium, Inc.'s debt has decreased relative to shareholder equity from 0.02 last year to 0.01 today, signaling strengthened financials

Equillium, Inc. has a net cash position, so leverage is healthy.

Equillium, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Equillium, Inc.'s profit margin has increased (-100.00%) in the last year from -19.63% to 0.00%, signaling increasing performance

Equillium, Inc.'s short-term assets of $30.28M exceed its short-term liabilities of $2.93M

Equillium, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Equillium, Inc.'s return on equity of -61.43%, is lower than 15.00%, indicating bad performance

Equillium, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Equillium, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

Equillium, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Equillium, Inc. has negative free cash flow, indicating cash burn

Equillium, Inc.'s yearly earnings has decreased 177.65% since last year from $-8.07M to $-22.40M, signaling decreasing performance

Equillium, Inc.'s yearly revenue has decreased 99.68% since last year from $41.09M to $130.00K, signaling decreasing performance

ROIC -33.86% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Equillium, Inc.'s 3-year revenue CAGR of -100.00% is negative, indicating declining revenue over the past 3 years

Equillium, Inc. had revenue growth in 4 out of 5 years, indicating consistent revenue performance

Equillium, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

Equillium, Inc. has insufficient data to evaluate this check.

Equillium, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Equillium, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Equillium, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Equillium, Inc. has insufficient data to evaluate this check.

Equillium, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Equillium, Inc. has a price-to-book ratio of 3.54x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Equillium, Inc. has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue